AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

PETS · NASDAQ · Specialty Retail

PetMed Express (PETS)

Supplies pet medicines and health products directly while extending its pharmacy platform to retail partners.

$1.57

vs last close−0.00 (−0.32%)

In millions of USD, except per-share figures

In millions	Q2 FY24Sep 2023	Q3 FY24Dec 2023	Q4 FY24Mar 2024	Q1 FY25Jun 2024	Q2 FY25Sep 2024	Q3 FY25Dec 2024	Q4 FY25Mar 2025	Q1 FY26Jun 2025	Q2 FY26Sep 2025	Q3 FY26Dec 2025	Q4 FY26Mar 2026	Q1 FY27Jun 2026
Revenue	71	65	67	68	60	53	46	51	44	41	43	41
Cost of revenue	53	47	50	52	42	38	28	39	32	31	36	30
Gross profit	18	18	16	16	17	15	19	12	12	9	7	11
	17	21	20	12	17	15	25	19	21	20	13	18
	17	19	20	12	15	14	22	19	19	18	17	15
Selling & marketing	6	6	6	7	5	3	9	6	4	5	6	4
General & administrative	12	13	14	5	10	11	12	13	14	12	11	11
Other expenses	0	2	0	0	2	2	3	0	2	2	−5	2
Operating income	1	−3	−4	4	1	0	−6	−7	−8	−10	−6	−6
	0	0	0	0	0	0	0	−27	0	0	2	0
Interest income	1	0	0	0	0	0	0	0	0	0	1	0
Interest expense	0	0	0	0	0	0	0	0	0	0	0	0
Other non-operating income	0	0	0	0	0	0	−1	27	0	0	0	0
Income before tax	1	−3	−3	5	1	0	−6	−34	−9	−11	−4	−6
Income tax expense	1	−1	2	1	−1	0	6	0	0	0	0	0
Net income from continuing operations	1	−2	−5	4	2	−1	−12	−34	−9	−11	−4	−6
Net income	1	−2	−5	4	2	−1	−12	−34	−9	−11	−4	−6
EPS, basic	$0.04	−$0.10	−$0.25	$0.18	$0.11	−$0.03	−$0.56	−$1.65	−$0.41	−$0.50	−$0.19	−$0.28
EPS, diluted	$0.03	−$0.10	−$0.25	$0.18	$0.11	−$0.03	−$0.56	−$1.65	−$0.41	−$0.50	−$0.19	−$0.28
Weighted average shares, basic	20	20	20	21	21	21	21	21	21	21	21	22
Weighted average shares, diluted	20	20	20	21	21	21	21	21	21	21	21	22
EBITDA	3	−1	−2	6	2	1	−3	−32	−6	−8	−3	−5
Depreciation & amortization	2	2	2	2	2	2	2	2	2	2	2	2
EBIT	1	−3	−3	4	1	0	−5	−34	−8	−10	−6	−7